Heart Disease Treatment Utilizes Mesenchymal Stem Cells [MSCs]

Cell-Kro has the potential to rebuild damaged portions of the heart using the patient’s own stem cells.

Researchers from the University of Vermont have developed a novel and effective application of mesenchymal stem cells [the same type found in Dental Stem Cells] to treat heart disease. The MSCs, when transplanted along with cardiac stem cells into the heart [in an animal model], produced a “cocktail” of protective ligands that improved the grafting success of the cardiac stem cells.

This new tool, called Cell-Kro, utilizes the unique properties of MSCs to facilitate stem cell treatments for heart disease that were previously unsuccessful.  In the future, the Cell-Kro would allow heart attack patients to use their own stem cells to re-build damaged portions of their hearts.

Mesenchymal stem cells have the unique capacity to regenerate a multitude of different types of tissues – such as neurons, insulin producing pancreatic beta cells, bone, cartilage, and cardiomyocites amongst them.  This University of Vermont study is just one example of the utility of stem cells in successfully treating diseases previously considered to be untreatable. To learn how to bank your own valuable stem cells to insure access to emerging regenerative therapies, visit www.stemsave.com  or call 877-783-6728 877-StemSave) today.

 

To view the full article, click here.

 

The Future of Regenerative is Now™.